1CP
HQL

1607 Capital Partners’s abrdn Life Sciences Investors HQL Stock Holding History

1607 Capital Partners’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
104,063
-11,007
-10% -$184K 0.12% 104
2025
Q4 		$1.93M Sell
115,070
-7,100
-6% -$119K 0.13% 87
2025
Q3 		$1.89M Sell
122,170
-39,801
-25% -$545K 0.14% 85
2025
Q2 		$2.07M Sell
161,971
-19,000
-10% -$234K 0.17% 92
2025
Q1 		$2.3M Sell
180,971
-66,176
-27% -$896K 0.19% 82
2024
Q4 		$3.24M Sell
247,147
-102,354
-29% -$1.48M 0.26% 79
2024
Q3 		$5.27M Sell
349,501
-69,778
-17% -$1.06M 0.48% 59
2024
Q2 		$5.94M Sell
419,279
-62,100
-13% -$840K 0.53% 56
2024
Q1 		$6.56M Buy
481,379
+1,200
+0.2% +$16.6K 0.54% 55
2023
Q4 		$6.46M Buy
480,179
+764
+0.2% +$9.4K 0.45% 65
2023
Q3 		$5.98M Hold
479,415
– – 0.45% 61
2023
Q2 		$6.49M Buy
479,415
+15,700
+3% +$217K 0.47% 59
2023
Q1 		$6.46M Buy
463,715
+73,984
+19% +$1.06M 0.45% 61
2022
Q4 		$5.54M Buy
389,731
+304,830
+359% +$4.42M 0.38% 69
2022
Q3 		$1.16M Buy
+84,901
New +$1.27M 0.09% 115
2021
Q4 		– Sell
-10,000
Closed -$208K – 116
2021
Q3 		$208K Sell
10,000
-100,901
-91% -$2.16M 0.01% 105
2021
Q2 		$2.38M Sell
110,901
-48,842
-31% -$986K 0.11% 87
2021
Q1 		$3.15M Sell
159,743
-43,245
-21% -$891K 0.15% 93
2020
Q4 		$4.01M Hold
202,988
– – 0.2% 78
2020
Q3 		$3.57M Buy
202,988
+27,964
+16% +$501K 0.19% 82
2020
Q2 		$3.14M Buy
175,024
+101,513
+138% +$1.74M 0.17% 84
2020
Q1 		$1.1M Buy
+73,511
New +$1.2M 0.07% 113

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

1607 Capital Partners's HQL Position: Q1 2026 in Review

1607 Capital Partners reduced its abrdn Life Sciences Investors (HQL) stake by 9.6% in Q1 2026, selling an estimated $184K and leaving 104,063 shares worth $1.69M. The position accounts for 0.12% of the portfolio, ranked #104.

1607 Capital Partners first reported a position in HQL in Q1 2020 and has held it in 22 quarters since. The position peaked at $6.56M in Q1 2024. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • 1607 Capital Partners held 104,063 shares of abrdn Life Sciences Investors worth $1.69M as of Q1 2026.
  • 1607 Capital Partners sold 11,007 abrdn Life Sciences Investors shares in Q1 2026, an estimated $184K.
  • abrdn Life Sciences Investors made up 0.12% of 1607 Capital Partners's portfolio in Q1 2026, its #104 holding.
  • 1607 Capital Partners first reported a position in abrdn Life Sciences Investors in Q1 2020 and has held it in 22 quarters since.
  • 1607 Capital Partners's abrdn Life Sciences Investors position peaked at $6.56M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on 1607 Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.